Literature DB >> 11683516

Localization and characterization of neuropeptide receptors in human colon.

M Rettenbacher1, J C Reubi.   

Abstract

Information about the expression of neuropeptide receptors is limited in human peripheral tissues, such as the gastrointestinal tract, as compared to the brain. A detailed evaluation of binding sites for gastrin-releasing peptide (GRP), neuropeptide Y, vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating polypeptide (PACAP), gastrin/cholecystokinin, neurotensin, substance P and somatostatin was therefore undertaken in human colon using in vitro receptor autoradiography and subtype characterization with receptor-selective ligands. GRP receptors, Y2 receptors, PACAP type1-receptors, cholecystokinin-A receptors, neurotensinl and sst2 receptors were abundantly expressed in the myenteric plexus. Y2, neurotensinl and sst2 receptors were also strongly expressed in the submucosal plexus. Furthermore, expression of GRP receptors, neurokinin (NK)1 receptors, VIP type2-receptors and sst2 receptors was found in the mucosa-directed margin of the circular smooth muscle where the interstitial cells of Cajal are located. A variable and complementary expression of GRP receptors, VIP/PACAP receptors, Y2 neurotensinl, NK1 and somatostatin receptors was found in the circular and longitudinal smooth muscle. NK1 and Y1 receptors were often detected in arteries and veins, while VIP/PACAP and sst2 receptors were found in lymphoid follicles. Y2, VIP type, and sst2 receptors were present in the colonic mucosa. Y2 was strongly expressed in the muscularis mucosae. This study shows that neuropeptide receptors are expressed in high amounts and in highly specific patterns in distinct targets in the human colon, suggesting a major physiological role for these peptides. The data represent the molecular basis to investigate the regulation by neuropeptides of colonic functions and to develop neuropeptide drugs aimed at interacting with these receptors in colonic diseases, such as Hirschsprung's and Crohn's diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683516     DOI: 10.1007/s002100100454

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes.

Authors:  Luis E Gimenez; Stefanie Babilon; Lizzy Wanka; Annette G Beck-Sickinger; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

2.  Progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA expression in non-tumor tissues of the human gastrointestinal tract.

Authors:  Hans-Jurg Monstein; Niclas Grahn; Mikael Truedsson; Bodil Ohlsson
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

Review 3.  What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.

Authors:  Ahmed M Elmansi; Mohamed E Awad; Nada H Eisa; Dmitry Kondrikov; Khaled A Hussein; Alexandra Aguilar-Pérez; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Sadanand Fulzele; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Brian F Volkman; William D Hill
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

4.  Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.

Authors:  F Guagnini; M Valenti; S Mukenge; I Matias; A Bianchetti; S Di Palo; G Ferla; V Di Marzo; T Croci
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

5.  Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway.

Authors:  M Fornai; R Colucci; L Antonioli; F Crema; P Buccianti; M Chiarugi; F Baschiera; N Ghisu; M Tuccori; C Blandizzi; M Del Tacca
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

Review 6.  Involvement of endogenous CCK and CCK1 receptors in colonic motor function.

Authors:  Gábor Varga; András Bálint; Beáta Burghardt; Massimo D'Amato
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

7.  Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.

Authors:  M de Visser; H F Bernard; J L Erion; M A Schmidt; A Srinivasan; B Waser; J C Reubi; E P Krenning; M de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-08       Impact factor: 9.236

8.  Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.

Authors:  W P ter Beek; E S M Muller; R A Van Hogezand; I Biemond; C B H W Lamers
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

9.  [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.

Authors:  Theodosia Maina; Anastasia Nikolopoulou; Eleni Stathopoulou; Athanassios S Galanis; Paul Cordopatis; Berthold A Nock
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-27       Impact factor: 9.236

10.  Inhibitory pathways in the circular muscle of rat jejunum.

Authors:  Gwen Vanneste; Patrick Robberecht; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.